Structure/Function Analysis of Icmt
Icmt的结构/功能分析
基本信息
- 批准号:7760070
- 负责人:
- 金额:$ 29.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:Antineoplastic AgentsAttentionBiochemicalBiochemistryBiologicalBiological ProcessBiologyBreast Cancer ModelBreast CarcinomaBreedingC-terminalCatalysisCatalytic DomainCellsCellular MembraneChemicalsCo-ImmunoprecipitationsCytosolDNA MethyltransferaseDNA Modification MethylasesDrug Delivery SystemsEnzymatic BiochemistryEnzymesFaceFarnesyl Transferase InhibitorFibroblastsGenesGeranyltranstransferaseGrowthGuanosine Triphosphate PhosphohydrolasesHRAS geneHumanIn VitroLaboratoriesLibrariesMaintenanceMalignant NeoplasmsMapsMediatingMembraneMembrane ProteinsMethodsMethylationMethyltransferaseModelingMonomeric GTP-Binding ProteinsMusN-terminalOncogenesOrthologous GenePathway interactionsPhylogenetic AnalysisPost-Translational Protein ProcessingProcessProtein FamilyProtein IsoformsProteinsProteolysisProteomicsPublicationsRas Signaling PathwayReactionRegulationRelative (related person)Research DesignResearch PersonnelResistanceRoleSequence AnalysisSeriesSignal TransductionSignaling MoleculeSmall Interfering RNAStructureTestingTimeTissuesTransgenic OrganismsYeastscancer therapyclinical efficacycrosslinkdrug discoveryexperiencefascinategenetically modified cellsin vivoinhibitor/antagonistinterestmembermutantneoplastic cellnovelnovel strategiespolypeptidepreclinical studyprenylationpromoterprotein-S-isoprenylcysteine O-methyltransferaserab GTP-Binding Proteinsras Proteinsrecombinaseresearch studyrhosuccesstraffickingtumortumorigenesis
项目摘要
Ras is the oncogene most often associated with human cancer. Accordingly, Ras is an attractive target for anti-
cancer drug discovery. Ras proteins are GTPases that are biologically active only when associated with cellular
membranes. Ras is the founding member of a large family of proteins that are targeted secondarily to cellular
membranes by the posttranslational modification of a C-terminal CAAX motif. CAAX sequences are modified
by prenylation, proteolysis and carboxyl methylation, reactions catalyzed respectively by farnesyl or geranyl-
geranyltransferases, Ras converting enzyme 1 (Reel) and isoprenylcysteine carboxyl methyltransferase (Icmt).
Farnesyl transferase inhibitors (FTIs) have been developed as anti-cancerdrugs. Recent evidence that cells deficient
in Reel or Icmt are resistant to transformation by Ras has sparked heightened interest in these enzymes as drug
targets. Cloned in our laboratory and shown to be an intrinsic ER membrane protein, little is known about the
structure, enzymology, regulation and biological function of Icmt. We have generated a library of Icmt mutants
and developed methods to study the structure and function of Icmt. A structure/function analysis of Icmt is the
subject of this proposal. The Specific Aims are: 1. Biochemical analysis of Icmt. Using point and truncation
mutants, photoaffinity and chemical crosslinking of substrates and co-immunoprecipitation we will map catalytic
and regulatory domains of Icmt. Using conventional and novel approaches we will map the topology of thismultiple
membrane spanning enzyme. 2. Functional analysis of Icmt in vitro: role in small GTPase signaling. Using
mouse fibroblasts deficient in Icmt and human cells in which the Icmt gene is silenced we will study the role of
Icmt in the function and stability of Ras, Ral, Rho and Rab GTPases. We will also study, at the protein level, the
expression of Icmt in normal and tumor cells 3. Functional analysis of Icmt in vivo: role in an H-Ras driven
mouse mammary tumor model. Using Icmtnox/n¿x mice we will test the hypothesis that Icmt is required for
oncogenesis and tumor maintenance in vivo using a murine model of Ras-driven mammary carcinoma that is both
tissue specific and temporally controllable. The studies proposed in this application will elucidate the biochemistry
and biology of an enzyme that modifies a host of signaling GTPases and will inform the ongoing effort to develop
anti-cancer drugs that act on the Ras trafficking pathway. '¿]'¿ '"¿ '¿ ¿ ' "¿ ¿ ' -1-' Ir
Ras是最常与人类癌症相关的致癌基因。因此,Ras是一个有吸引力的靶标
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK Reid PHILIPS其他文献
MARK Reid PHILIPS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK Reid PHILIPS', 18)}}的其他基金
FASEB SRC: Structure and Function of Small GTPases
FASEB SRC:小 GTP 酶的结构和功能
- 批准号:
10463260 - 财政年份:2022
- 资助金额:
$ 29.13万 - 项目类别:
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
RAS 膜运输揭示的差异功能和肿瘤脆弱性
- 批准号:
10468873 - 财政年份:2020
- 资助金额:
$ 29.13万 - 项目类别:
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
RAS 膜运输揭示的差异功能和肿瘤脆弱性
- 批准号:
10688011 - 财政年份:2020
- 资助金额:
$ 29.13万 - 项目类别:
Regulation of KRAS Trafficking and Signaling by GPR31
GPR31 对 KRAS 贩运和信号传输的监管
- 批准号:
10047185 - 财政年份:2020
- 资助金额:
$ 29.13万 - 项目类别:
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
RAS 膜运输揭示的差异功能和肿瘤脆弱性
- 批准号:
10237382 - 财政年份:2020
- 资助金额:
$ 29.13万 - 项目类别:
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
RAS 膜运输揭示的差异功能和肿瘤脆弱性
- 批准号:
10053541 - 财政年份:2020
- 资助金额:
$ 29.13万 - 项目类别:
Role of nonsense mediated RNA decay in pancreatic cancer
无义介导的RNA衰变在胰腺癌中的作用
- 批准号:
10229380 - 财政年份:2018
- 资助金额:
$ 29.13万 - 项目类别:
Role of nonsense mediated RNA decay in pancreatic cancer
无义介导的RNA衰变在胰腺癌中的作用
- 批准号:
9447641 - 财政年份:2018
- 资助金额:
$ 29.13万 - 项目类别:
相似国自然基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Integrating the neural and biochemical basis of attention in humans
整合人类注意力的神经和生化基础
- 批准号:
RGPIN-2019-05690 - 财政年份:2022
- 资助金额:
$ 29.13万 - 项目类别:
Discovery Grants Program - Individual
Integrating the neural and biochemical basis of attention in humans
整合人类注意力的神经和生化基础
- 批准号:
RGPIN-2019-05690 - 财政年份:2021
- 资助金额:
$ 29.13万 - 项目类别:
Discovery Grants Program - Individual
Integrating the neural and biochemical basis of attention in humans
整合人类注意力的神经和生化基础
- 批准号:
RGPAS-2019-00020 - 财政年份:2020
- 资助金额:
$ 29.13万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
Integrating the neural and biochemical basis of attention in humans
整合人类注意力的神经和生化基础
- 批准号:
RGPIN-2019-05690 - 财政年份:2020
- 资助金额:
$ 29.13万 - 项目类别:
Discovery Grants Program - Individual
Integrating the neural and biochemical basis of attention in humans
整合人类注意力的神经和生化基础
- 批准号:
RGPAS-2019-00020 - 财政年份:2019
- 资助金额:
$ 29.13万 - 项目类别:
Discovery Grants Program - Accelerator Supplements
Integrating the neural and biochemical basis of attention in humans
整合人类注意力的神经和生化基础
- 批准号:
DGECR-2019-00438 - 财政年份:2019
- 资助金额:
$ 29.13万 - 项目类别:
Discovery Launch Supplement
Integrating the neural and biochemical basis of attention in humans
整合人类注意力的神经和生化基础
- 批准号:
RGPIN-2019-05690 - 财政年份:2019
- 资助金额:
$ 29.13万 - 项目类别:
Discovery Grants Program - Individual
BIOCHEMICAL MECHANISMS UNDERLYING IMPAIRED ATTENTION
注意力受损的生物化学机制
- 批准号:
2259363 - 财政年份:1992
- 资助金额:
$ 29.13万 - 项目类别:
BIOCHEMICAL MECHANISMS UNDERLYING IMPAIRED ATTENTION
注意力受损的生物化学机制
- 批准号:
3084606 - 财政年份:1992
- 资助金额:
$ 29.13万 - 项目类别:
BIOCHEMICAL MECHANISMS UNDERLYING IMPAIRED ATTENTION
注意力受损的生物化学机制
- 批准号:
2259362 - 财政年份:1992
- 资助金额:
$ 29.13万 - 项目类别:














{{item.name}}会员




